Kevin J. Alker
Kevin J. Alker publishes mostly in Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Cardiac Ischemia and Reperfusion, Cardiac electrophysiology and arrhythmias and Cardiac Imaging and Diagnostics.
- World rank
- #1,817,290 of 7,710,434 ranked researchers
- Rank in United States
- #557,908 of 1,627,098
- Works
- 29
- Citations
- 1.6k
- Citations per work
- 53.8
What does Kevin J. Alker research?
Kevin J. Alker's work is mostly in Medicine (61%), Pharmacology, Toxicology and Pharmaceutics (6%), Engineering (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1861.2%
- Medicine1861.2%
- Everything else827.0%
- Life Sciences25.9%
- Physical Sciences25.9%
- Engineering25.9%
- 1Cardiology and Cardiovascular Medicine31% of their works
- 2Pathology and Forensic Medicine14% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Toxicology6% of their works
- 5Biomedical Engineering6% of their works
- 6Surgery6% of their works
Research topics
- Cardiac Ischemia and Reperfusion
- Cardiac electrophysiology and arrhythmias
- Cardiac Imaging and Diagnostics
- Forensic Toxicology and Drug Analysis
- Pharmacological Receptor Mechanisms and Effects
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Coronary Interventions and Diagnostics
Which keywords describe Kevin J. Alker's research?
The keywords of their largest research topics: Myocardial Infarction, Calcium Signaling, Cardioprotection, Ischemia-Reperfusion Injury, Arrhythmias, Long-QT Syndrome, Cardiac Imaging and Coronary Artery Disease.
- Sudden Death
- Myocardial Revascularization
- Coronary Stents
- Chamber Quantification
- Forensic Toxicology
- Coronary Artery Disease
- Long-QT Syndrome
- Ischemia-Reperfusion Injury
- Calcium Signaling
- Myocardial Infarction
- Cardioprotection
- Arrhythmias
- Cardiac Imaging
- Drug Analysis
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Chaperone
- Echocardiography
- Sigma-1 Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Myocardial Infarction182 topics
- Calcium Signaling142 topics
- Cardioprotection111 topic
- Ischemia-Reperfusion Injury111 topic
- Arrhythmias101 topic
- Long-QT Syndrome101 topic
- Cardiac Imaging71 topic
- Coronary Artery Disease71 topic
- Drug Analysis51 topic
- Forensic Toxicology51 topic
- Arrhythmogenic Right Ventricular Cardiomyopathy41 topic
- Chamber Quantification41 topic
- Chaperone41 topic
- Coronary Stents41 topic
- Echocardiography41 topic
- Myocardial Revascularization41 topic
- Sigma-1 Receptor41 topic
- Sudden Death41 topic
Where does Kevin J. Alker work?
Kevin J. Alker's main affiliation in the publication record is Good Samaritan Hospital, United States.
How many publications and citations does Kevin J. Alker have?
OpenAlex counts 29 works and 1,560 citations for Kevin J. Alker, an h-index of 15, ranking #1,817,290 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kevin J. Alker. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.